Growing community of inventors

Chatillon, France

Patricia Lepage

Average Co-Inventor Count = 5.87

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Patricia LepageLaurence Zitvogel (2 patents)Patricia LepageIvo Gomperts Boneca (2 patents)Patricia LepageSophie Viaud (2 patents)Patricia LepageRomain Daillere (2 patents)Patricia LepageCarole Schwintner (1 patent)Patricia LepageHervé Affagard (1 patent)Patricia LepageJoël Dore (1 patent)Patricia LepageCatherine Juste (1 patent)Patricia LepageFernanda Fonseca (1 patent)Patricia LepageChristel Maillet (1 patent)Patricia LepageSylvie Rabot (1 patent)Patricia LepageHervé Blottiere (1 patent)Patricia LepagePatricia Lepage (3 patents)Laurence ZitvogelLaurence Zitvogel (20 patents)Ivo Gomperts BonecaIvo Gomperts Boneca (2 patents)Sophie ViaudSophie Viaud (2 patents)Romain DaillereRomain Daillere (2 patents)Carole SchwintnerCarole Schwintner (8 patents)Hervé AffagardHervé Affagard (7 patents)Joël DoreJoël Dore (5 patents)Catherine JusteCatherine Juste (2 patents)Fernanda FonsecaFernanda Fonseca (2 patents)Christel MailletChristel Maillet (1 patent)Sylvie RabotSylvie Rabot (1 patent)Hervé BlottiereHervé Blottiere (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Institut National De La Sante Et De La Recherche Medicale (2 from 1,743 patents)

2. Institut Gustave Roussy (2 from 95 patents)

3. Université Paris-Saclay (2 from 78 patents)

4. Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement (2 from 40 patents)

5. Maat Pharma (1 from 9 patents)

6. Institut De La Recherche Agronomique (1 from 2 patents)


3 patents:

1. 11344586 - Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment

2. 10980839 - Method of preparing a faecal microbiota sample

3. 10646521 - Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…